glutathione and triple negative breast cancer Ferroptosis heterogeneity in triple-negative reveals an innovative immunotherapy combination strategy Ferroptosis heterogeneity in triple-negative breast
Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy: Cell Metabolism Glutathione peroxidase 4 (GPX4) and obesity interact to impact tumor progression and treatment response in triple negative breast cancer Cancer & Metabolism Springer Nature Link CD36 enhances sensitivity of triple negative breast cancer cells to palmitate induced ferroptosis Cell Death & Disease Metabolic interplay between exogenous cystine and glutamine dependence in triple negative breast cancer Cell Death Discovery
Pay in 4 interest-free payments of $6.03 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



